News

Thumbnail

New research published in JAMA Internal Medicine compared current USPSTF criteria to a potential shift toward total years smoked, rather than pack years. 

artificial intelligence

Researchers recently sought to better understand how patients perceive rapidly evolving advancements in AI, sharing their findings in RSNA’s Radiology

Thumbnail

An analysis from cybersecurity consultancy group Omega Systems reveals that most healthcare practices place too much trust in their third-party vendors to secure patient data, neglecting their own IT systems in the process.

emergency

An emergency department nurse at Heritage Valley Sewickley Hospital is accused of stealing drugs and neglecting patients, causing at least two fatalities. A lawsuit filed by two whistleblowers further alleges that hospital leadership covered for the drug-dependent nurse.

trump and his healthcare leaders

The Trump administration said the reduction can be attributed to a cleanup of fraud, waste and abuse, but the real reason extends back to enhanced subsidies put in place during the COVID-19 pandemic.

Medicaid protesters

Led by Massachusetts and California, the plaintiffs say CMS ignored the will of Congress by strictly defining a “medically frail” exemption that would allow a person access to safety net medical coverage.

intensive care ICU

Memo to health execs: If your hospital hasn’t had a C. auris scare yet, odds are quite high that it soon will. 

the words "FDA recall" on a board

The issue could cause a reader to unintentionally report on the wrong patient when using interactive applications, according to a notice from the FDA. 

old woman or doctor shaking hands with patient

Three out of four TTEs are being ordered by clinicians who are not cardiologists. Could this be having a negative impact on patient care?

The Medtronic Liberant thrombectomy system.

The new device uses an advanced algorithm to regulate aspiration and conserve blood. Ajit Rao, MD, a vascular surgeon with The Mount Sinai Hospital, performed the historic procedure.

Milestone Pharmaceuticals has received U.S. Food and Drug Administration (FDA) approval for etripamil, a new nasal spray for adult patients with paroxysmal supraventricular tachycardia (PSVT).

Milestone Pharmaceuticals will be selling etripamil under the brand name Cardamyst. It is expected to hit the U.S. market in early 2026.

money business cash flow dollar

Massachusetts-based SpectraWAVE has gained considerable momentum in recent years, planting its flag in some of cardiology’s biggest trends. The company was co-founded by cardiologists and has already secured multiple FDA clearances.

Around the web

New research published in JAMA Internal Medicine compared current USPSTF criteria to a potential shift toward total years smoked, rather than pack years. 

Researchers recently sought to better understand how patients perceive rapidly evolving advancements in AI, sharing their findings in RSNA’s Radiology

An analysis from cybersecurity consultancy group Omega Systems reveals that most healthcare practices place too much trust in their third-party vendors to secure patient data, neglecting their own IT systems in the process.